Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
1
Allen R. Nissenson, MD, FACPChief Medical Officer, DaVita
Emeritus Professor of Medicine, David Geffen School of Medicine at UCLA
Kidney Careof the Future
2
Abraham Lincoln
The best way to predict your future is to create it.
3
What Is The Future Of Health Care?
“All signs point to a retail market.”- Health Care Advisory Board
“The combination of economic and technological changes is creating much more of a empowered, informed consumer market.”
- McKinsey & Co.
“Multiple, intersecting pressures will drive the transformation of health care delivery and financing from volume- to value-based payments over the next decade.”
- American Hospital Association
“In 2020, informed and demanding patients are now partners in their own healthcare….Health data is pervasive – requiring new tools and provider models.”
- Deloitte
4
Trends in Vertical Integration
Companies from other
segments are becoming providers
http://www.healthleadersmedia.com/content/HEP-295415/1-in-5-Health-Systems-to-Become-payors-by-2018##
Payers are becoming providers
Providers are becoming
payers
5
Number of Hospitals in Health Systems,
2002 – 2012
Hos
pita
ls
2,400
2,500
2,600
2,700
2,800
2,900
3,000
3,100
3,200
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Avalere Health analysis of American Hospital Association Annual Survey data, 2012, for community hospitals.
6
Why ESRD Matters
7
Why Renal Care Is Important
Other Medicare
Other Medicare
1USRDS 2011 2~375K ESRD + ~300K Stage 4 Chronic Kidney Disease
ESRD +Late Stage CKD
~$30Bper year
~1.5%OF PATIENTS1,2
~10%OF COSTS
8
Total Medicare Dollars Spent on ESRDBy type of service
2014 USRDS ESRD Database. Total Medicare costs from claims data; includes all Medicare as primary payer claims as well as amounts paid by Medicare as secondary payer.
9
• Consolidate our fragmented delivery system – Dialysis facility – Nephrology practice – Hospital systems
Key Issues: Dialysis Providers
Dialysis 20%
Out- patient costs 34%
Part D meds 6%
Hospital- izations
39%
9
10
Filled and Unfilled NRMPNephrology Fellow Programs
0
38
75
113
150
2010 2011 2012 2013 2014
64
34242415
81114118122127
Filled Unfilled
Source: NRMP
Num
ber o
f Pro
gram
s
11
• Clinics
• NPs / PAs
• Patient outcomes
• Care of hospitalized patients
Future Role of Nephrologists =Oversight of. . .
12
• Improving outcomes in dialysis
• New approaches needed
• Delivery systems of the future
• Reimbursement systems of the future
Presentation Outline
13
What Matters Most
Measures of Effectiveness
Complex Programs
The Fundamentals
Clinical Quality PyramidNissenson, Allen R. "Improving Outcomes for ESRD Patients: Shifting the Quality Paradigm." CJASN 2014.
14
14
16
19
21
23
96 97 98 99 00 01 02 03 04 05 06 07 08 09 10 11 12
22.517.1
Death Rate (Prevalent Dialysis Patients)
Dea
th R
ate
Per 1
00 P
atie
nt-Y
ears
Collins, ASN, Peer (2015); http://www.peerkidney.org/
15
First-Year Hospital Admission Rates (Incident Dialysis Patients)
1.30
1.65
2.00
2.35
2.70
99 00 01 02 03 04 05 06 07 08 09 10 11 12Adm
issi
on R
ates
Per
Pat
ient
-Yea
r
YearCollins, ASN, Peer (2015); http://www.peerkidney.org/
16
1.60
1.78
1.95
2.13
2.30
99 00 01 02 03 04 05 06 07 08 09 10 11 12
Hospital Admission Rates(Prevalent Dialysis Patients)
Adm
issi
on R
ates
Per
Pat
ient
-Yea
r
Collins, ASN, Peer (2015); http://www.peerkidney.org/
17
30-Day Readmission Rates Among Live Discharges (Chronic Dialysis Patients)
30.0
31.0
32.0
33.0
34.0
35.0
1996 1998 2000 2002 2004 2006 2008 2010 2012For 1996-2011, 30-day readmission rate was calculated for live discharge Jan 1- Dec 31; For 2012, 30-day readmission rate was calculated for live discharge Jan 1 - June 30, 2012
Collins, ASN, Peer (2015); http://www.peerkidney.org/
30-D
ay R
eadm
issi
on R
ate
18
• Improving outcomes in dialysis
• New approaches needed
• Delivery systems of the future
• Reimbursement systems of the future
Presentation Outline
19
The Triple Aims
of Health Care
Improve
experience of care
Impr
ove
healt
h
of p
opul
atio
n
Reduce health care costsDonald M. Berwick, Thomas W. Nolan, and John Whittington. “The Triple Aim: Care, Health, and Cost,” Health Affairs, Vol. 27 No. 3 (May, 2008): 759-769
20
MarketEvolution
Regulators
Payors
ConsumersCollaboration
Technology
“Forcing” providers to deliver high quality careat a lower cost with high patient experience
21
Risk is shifting to the natural owner
General Population
Health
PCPs/ Specialists
Episodic
Scale/Skill Providers
Chronic
Scale/Skill Providers
Catastrophic
Payors
“Lifestyle” conditions
The Consumer
22
• Improving outcomes in dialysis
• New approaches needed
• Delivery systems of the future
• Reimbursement systems of the future
Presentation Outline
23
Providers must be able to:• Allocate resources to deliver population-level care in area of
core competency
• Leverage economies of scope and scale to allow these same resources to fund research
• Develop and implement key programs to furtherimprove outcomes
To Achieve the Triple Aim. . .
Innovation in the health care model is required
23
24
Innovation in the Delivery Model
• Provider-centric
• Volume driven
• Quality given “attention”
• No focus on inefficiency
• Lack of alignment
• Safety??
• Patient-centric
• Quality driven
• Utilization focused
• Collaboration focus
• Safety focus
• Value-based arrangements
• Bigger bundles
PAST FUTURE
24
25
What Matters Most
Measures of Effectiveness
Complex Programs
The Fundamentals
Clinical Quality PyramidNissenson, Allen R. "Improving Outcomes for ESRD Patients: Shifting the Quality Paradigm." CJASN 2014.
26
2016 Focus
1) Mortality
2) Hospitalization
3) Patient experience
4) Physician experience
5) Publicly-reported data
6) “Upstream”- mid/late CKD
7) Triple Aim
27
Calendar Year (Payment Year)
2015 (2017)
2016 (2018)
2017 (2019)
Performance Metrics
• Weight: 75% •• AVF/CVC (16%) • Kt/V (16%) • SIR (16%) • Ca (11%) • SRR (16%)
• Weight: 90% •• AVF/CVC (18%) • Kt/V (18%) • SIR (20%) • Ca (7%) • SRR (10%) • STrR (7%) • CAHPS x2 * (20%)
• Weight: 90% •• AVF/CVC (18%) • Kt/V (18%) • SIR (20%) • Ca (7%) • SRR (10%) • STrR (7%) • CAHPS x2 * (20%)
Reporting Metrics • Weight: 25% •• CAHPS x2 • Phos • Anemia
• Weight: 10% •• Phos • Anemia • Dep Screening • Pain Assmt • HCP Flu Vacc
• Weight: 10% •• Phos • Anemia • Dep Screening • Pain Assmt • HCP Flu Vacc
TPS • 60 • 49 • TBD
QIP
28 *SRR is currently reported on Dialysis Facility Compare, but not part of Five-Star
Five-Star
Calendar Year (Publish Date)
2015 Performance (Oct 2016)
2016 Performance (Oct 2017)
2017 Performance (Oct 2018)
Current Metrics
• AVF/CVC • Kt/V • Ca • SMR • SHR • STrR
• AVF/CVC • Kt/V • Ca • SMR • SHR • STrR
• AVF/CVC • Kt/V • Ca • SMR • SHR • STrR
Probable New Metrics
• SRR •• SRR* • CAHPS • SIR • Pedi Kt/V
• SRR* • CAHPS • SIR • Pedi Kt/V • UFR • Others?
29
Most Important Measures When Evaluating The Overall Quality of the Facility
Percent of responsesTotal
(n=653)
DPC Members (n=394)
DPC Non-Members
(n=259)
Dialysis Center Staff Respect/Listening 58 59 56
Physical Comfort during Dialysis 42 41 42
Kt/V Dialysis Adequacy 41 43 38
Dialysis Patient Education 40 40 42
Healthcare-Acquired Infections 30 28 32
Anemia Management 29 32* 25
Patient Mortality and Hospitalizations 26 29* 22
Quality of Life – Cramping 25 21 30*
Healthy Days at Home 25 25 24
DPC Survey
*Statistical significance at the 90% level
30
DaVita Home Dialysis System
Remote Monitoring
Risk Model
Health Management
Smart Phone App
Physician Partners
31
• Improving outcomes in dialysis
• New approaches needed
• Delivery systems of the future
• Reimbursement systems of the future
Presentation Outline
32
Manage the Costly CKD to ESRD Transition
Cos
t $ P
PPM
0
10,000
20,000
30,000
40,000
-6 -5 -4 -3 -2 -1 1 2 3 4 5 6
Average PPPM Cost Through Transition to Dialysis
CKD IV / V ESRD
Months on Pre- and Post-Initiation of Dialysis
Delay CKD Progression
Transition to Dialysis
(>30% mortality)Prepare for Dialysis (40% crash)
Manage Hospitalizations (58% avoidable,
36% readmit rate)
For Commercial member; based on MarketScan data, from 2010 USRDS ADR, Volume 1, Page 137. MarketScan is a commercial claims dataset comprised of 10.5 million covered lives that USRDS uses as a benchmark for CKD utilization.
33
• Top quartile to top 1% of health care costs
• Average of eight comorbidities – CV disease – 50% end-stage CV disease, CHF or CKD
• 20% of spending post hospitalization
• Significant depression and bipolar disease
Most Vulnerable Medicare Patients
Powers, Brian W., and Sreekanth K. Chaguturu. “ACOs And High-Cost Patients". NEJM 374.3 (2016): 203-205.
34
• Group of doctors / hospital system paid a fixed amount for all services for enrollees
• Providers accept the risk
• Effective and predictable
• Opposite end of payment spectrum from FFS – Many other models seen as “stepping stones” from FFS
to capitation
Capitation Overview
35
• Pay more than Medicare rate if quality metrics are met
• Pay if specific quality metrics are achieved – Admission rates – Catheter rates – Readmission rates
Capitation: Inclusion of Quality Measures Mitigates Any Temptation to “Skimp”
36
• Medicare “Special Needs Plan”
• Integrated care model for ESRD patients(and other select chronic diseases)
• Dialysis patients cannot newly enroll in MA plans, but they can enroll in an ESRD SNP
• Risk-adjusted global capitated payment from CMS; health plan and provider share in surplus after medical expenditures
SNP Overview
37
• Los Angeles-Orange County
• Launched in 2014
• Partnership between… – DaVita VillageHealth – HealthCare Partners – SCAN health plan
• Exemplary clinical results to- date (e.g., hospitalization rate, CVC rate)
SNP Example
38
Full-Risk Example: Achieving the Triple Aim in ESRD C-SNP
Better than the Medicare fee-for-service sample.
15% per year.$8,000
92%Satisfaction rating in Medicare’s CAHPS 2013 survey.
Non-dialysis cost savings:
Nearly
Per member per year savings:
39
ESCO Entity Structure
Each ESCO will have a Governing Body with final decision authority to execute functions of ESCO
ESCO PARTICIPANTS
Dialysisfacilities
Nephrology group(s)
OPTIONAL: Hospitals, MSGs,other providers
40
ESCO Participant Framework
Hospitalization Management
ESCO Service Areas
Medication Management
Fluid Management
Diabetes Management
• ESRD patients receive treatment in the clinic3x / week 4−5 hrs / treatment (12−15 hrs /week)
• The core capabilities of the ESCO are driven by care coordination in the dialysis center
• Focus on the interventions that result in the highest quality and fewest complicationsDialysis Clinic
Patient Care Team
41
26 ESCO Quality Performance MeasuresMeasure TypeDomain: Patient Safety ESCO Standardized Mortality Ratio OutcomeDocumentation of Current Medications in the Medical Record ProcessBloodstream Infection in Hemodialysis Outpatients OutcomeFalls: Screening, Risk Assessment and Plan of Care to Prevent Future Falls ProcessDomain: Person- and Caregiver-Centered Experience and Outcomes Kidney Disease Quality of Life (KDQOL) Survey OutcomeAdvance Care Plan ProcessICH-CAHPS: Nephrologists’ Communication and Caring OutcomeICH-CAHPS: Quality of Dialysis Center Care and Operations OutcomeICH-CAHPS: Providing Information to Patients OutcomeICH-CAHPS: Rating of Kidney Doctors OutcomeICH-CAHPS: Rating of Dialysis Center Staff OutcomeICH-CAHPS: Rating of Dialysis Center OutcomeDomain: Communication and Care Coordination ESCO Standardized Hospitalization Ratio for Admissions OutcomeESCO Standardized Readmission Ratio OutcomeMedication Reconciliation Post Discharge ProcessDomain: Clinical Quality of CareDiabetes Care: Eye Exam ProcessDiabetes Care: Foot Exam ProcessHemodialysis Adequacy: Minimum Delivered Hemodialysis Dose OutcomeProportion of Patients with Hypercalcemia OutcomePeritoneal Dialysis Adequacy: Delivered Dose of Peritoneal Dialysis Above Minimum OutcomeHemodialysis Vascular Access: Maximizing Placement of Arterial Venous Fistula ProcessHemodialysis Vascular Access: Minimizing Use of Catheters as Chronic Dialysis Access ProcessDomain: Population Health Influenza Immunization for the ESRD Population ProcessPneumonia Vaccination Status ProcessScreening for Clinical Depression and Follow-Up Plan ProcessTobacco Use: Screening and Cessation Intervention Process
42
43
Change is here.It will be different in each communityHow will you prepare?What will you do?
44
Abraham Lincoln
You cannot escape the responsibilityof tomorrow by evading it today.
45
Appendix
46
• Nearly 20 million US adults with CKD
• ESRD 0.9% of Medicare beneficiaries (<500,000), but about $31 billion in Medicare spending >7%)
• More than $85k per ESRD beneficiary (vs. ~$11k for all beneficiaries)
• Significant co-morbidities often present (depression, diabetes, CHF)
• “…An ounce of prevention”
Why ESRD Matters